Skip to content

Genetic insights into coronary heart disease: A multi-omics approach

Jul 2026 · Journal of environmental biology · 0 citations

TL;DR

Novel insights are revealed into CHD genetics, confirming known loci such as 9p21.3 (CDKN2B-AS1), COL4A2 and PHACTR1, while uncovering their broader functional roles in vascular remodelling, inflammation, and lipid metabolism.

Abstract

Aim: Coronary heart disease (CHD) is a leading cause of mortality worldwide, with a complex interplay of genetic and environmental factors influencing its development. Genome-wide association studies (GWAS) have identified multiple genetic loci associated with CHD, providing crucial insights into its pathophysiology. However, the full spectrum of genetic contributors and their biological mechanisms remains to be elucidated. Methodology: This study integrates GWAS data with various ontology analyses to identify key genetic determinants of CHD. Variants associated with CHD were retrieved from public datasets and analysed using bioinformatics tools to explore their biological significance. Pathway enrichment, protein-protein interaction (PPI) networks, and clustering algorithms delineated functional relationships among candidate genes. Additionally, microRNA (miRNA) interactions were assessed to understand post-transcriptional regulatory mechanisms. Results: These findings revealed novel insights into CHD genetics, confirming known loci such as 9p21.3 (CDKN2B-AS1), COL4A2 and PHACTR1, while uncovering their broader functional roles in vascular remodelling, inflammation, and lipid metabolism. Enrichment and miRNA analyses highlighted new regulatory layers involving TGF-beta and AGE-RAGE pathways, and miRNAs like hsa-miR-147b and hsa-miR-4790-5p, suggesting previously unrecognized mechanisms in CHD pathogenesis. Interpretation: This study contributes to understanding CHD genetics by integrating multi-omic data to highlight relevant genetic factors and associated biological pathways. Key words: Coronary heart disease, Functional enrichment analysis, Genome-wide association studies, Genetic risk factors, Precision medicine

View source

Similar papers

Review Open access Jul 2026

Genetics of cardiovascular disease: genes and polymorphisms in pathways underlying atherosclerosis and clinical events.

Genetic associations are interpreted within a pathway-oriented framework that organizes both established and emerging genes according to their functional roles in cardiovascular biology, and highlights the interconnection between the biological processes underlying disease development.

María José Párraga-Viúdez, M. Sánchez-Gutiérrez, Alba Quirós-Jiménez et al. · 0 citations
Jul 2026

Genetic insights into childhood obesity: A comprehensive bioinformatics analysis

A comprehensive genetic and molecular landscape underlying childhood obesity is delineated, reflecting its multifactorial pathogenesis, with implications for improving future prevention and management strategies for childhood obesity.

T. Govardhan, J. Brahmaiah, P. Kumar et al. · 0 citations
Review Jul 2026

The Genetics of Coronary Artery Disease: Insights from Genome-wide Association Studies.

This review examines the heritable underpinnings of CAD, focusing on the contributions of GWAS to the understanding of the disease, and highlights how GWAS findings are paving the way for personalized medicine through polygenic risk scores, targeted therapies, and pharmacogenomics-driven interventions for CAD.

Shruti Tomar, Vikas Kumar · 0 citations
Open access Aug 2026

Integrative cross-tissue transcriptome-wide association and metabolomic analysis reveals novel genetic risk loci for aortic aneurysm

An integrated cross-omics analysis identifies novel genetic loci and, crucially, uncovers specific nutrient-related metabolic pathways that mediate genetic risk in Aortic aneurysm and its subtypes.

Han-Xi Wang, Junjie Cheng, Jia-Li Yao et al. · 0 citations
Jul 2026

Integrated functional analysis of prostate cancer– associated genes: A multi-dataset bioinformatics approach

The identified genes, microRNAs, and pathways advance mechanistic understanding of disease vulnerability and may ultimately inform the development of biological markers and targeted therapeutic strategies for prostate cancer.

J. Brahmaiah, T. Govardhan, J. Kavya et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.